Latanoprost 0.005%-netarsudil 0.02% ophthalmic solution: 1 drop into the affected eye(s) once a day in the evening
Maximum dose: 1 drop/eye/day
Comment: Administration of other topical ophthalmic drugs to lower intraocular pressure (IOP) should be separated by at least 5 minutes.
Use: Reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension
Usual Adult Dose for Glaucoma (Open Angle)
Latanoprost 0.005%-netarsudil 0.02% ophthalmic solution: 1 drop into the affected eye(s) once a day in the evening
Maximum dose: 1 drop/eye/day
Comment: Administration of other topical ophthalmic drugs to lower intraocular pressure (IOP) should be separated by at least 5 minutes.
Use: Reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dose Adjustments
Missed doses:
If a dose is missed, patients should continue with the next dose in the evening.
The maximum daily dose is 1 drop in the affected eye per day.
Precautions
CONTRAINDICATIONS: None.
Safety and efficacy have not been established in pediatric patients.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
During administration, patients should avoid touching tip of the single-use vial to the eye or any surface.
Patients who require the use of other drugs to lower IOP should separate their administration by at least 5 minutes.
Storage requirements:
The manufacturer product information should be consulted.
Patient advice:
Patients should be instructed to avoid touching the vial tip to the eye or other surfaces.
Patients who wear contact lenses should remove contact lenses before administration; the lenses may be reinserted at least 15 minutes after administration.
Patients should be advised to speak to their healthcare provider if they become pregnant, intend to become pregnant, or are breastfeeding.
